Vertex Pharmaceuticals, a leading drugmaker based in Boston, has announced impressive financial performance in the third quarter. The company's profit has risen to $1.04 billion, or $3.97 per share, compared to $930.5 million, or $3.59 per share, in the same period last year. This exceeds analysts' expectations of $3.50 per share. When adjusting for one-time items, the adjusted … [Read more...] about Vertex Pharmaceuticals Reports Strong Q3 Results
Q3 results
Upstart Holdings Shares Slide After Disappointing Q3 Results
AI Financial Technology Company Reports Loss and Lower Revenue Shares of Upstart Holdings, the AI financial technology company, dropped 23% in premarket trading following the release of their third-quarter financial results. The company, known for its machine learning approach to credit risk assessment, reported a loss of $40.3 million, or 48 cents a share, for the quarter … [Read more...] about Upstart Holdings Shares Slide After Disappointing Q3 Results
